| 产品描述: | TC11 is a MCL1 degrader. TC11 is also a Caspase-9 and CDK1 activator. TC11 structurally relates to immunomodulatory drugs as phenylphthalimide derivative. TC11 induces apoptotic death caused by degradation of MCL1 during prolonged mitotic arrest |
| 靶点: |
CDK1;MCL1 ;Caspase-9 |
| 体外研究: |
TC11 (0~30 μM; 24 hours; KMS34 cells) induces cell death in KMS34. TC11 (5 μM; 0~48 hours; KMS34 cells) induces cell death occurs through an apoptotic pathway and downregulates MCL1 expression. TC11 (5 μM; 24 hours; KMS34 cells) induces M arrest. |
| 参考文献: |
1. Ichikawa D, et al. A phenylphthalimide derivative, TC11, induces apoptosis by degrading MCL1 in multiple myeloma cells. Biochem Biophys Res Commun. 2020;521(1):252-258.
2. Shiheido H, et al. A phthalimide derivative that inhibits centrosomal clustering is effective on multiple myeloma. PLoS One. 2012;7(6):e38878. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.102 ml |
15.509 ml |
31.017 ml |
| 5 mM |
0.62 ml |
3.102 ml |
6.203 ml |
| 10 mM |
0.31 ml |
1.551 ml |
3.102 ml |
| 50 mM |
0.062 ml |
0.31 ml |
0.62 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |